Premium
Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis
Author(s) -
STETLERSTEVENSON M.,
YUAN C. M.
Publication year - 2009
Publication title -
international journal of laboratory hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.705
H-Index - 55
eISSN - 1751-553X
pISSN - 1751-5521
DOI - 10.1111/j.1751-553x.2009.01176.x
Subject(s) - myelodysplastic syndromes , flow cytometry , medicine , premalignant lesion , pathology , oncology , immunology , cancer , bone marrow
Summary Flow cytometric immunophenotypic analysis is a well‐recognized and widely accepted adjuvant test to increase the sensitivity and specificity of diagnosis in potential myelodysplastic syndrome (MDS) cases. In addition, flow cytometric analysis provides prognostic information in MDS that is not available from other sources. The flow cytometric findings indicative of MDS and its value is a diagnostic adjunct are discussed.